Gross Profit - Intercept Pharmaceuticals Inc (F:I4P) - Alpha Spread
I

Intercept Pharmaceuticals Inc
F:I4P

Watchlist Manager
Intercept Pharmaceuticals Inc
F:I4P
Watchlist
Price: 17.52 EUR Market Closed
Market Cap: 732.8m EUR
Have any thoughts about
Intercept Pharmaceuticals Inc?
Write Note

Intercept Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intercept Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
I
Intercept Pharmaceuticals Inc
F:I4P
Gross Profit
$317.1m
CAGR 3-Years
3%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.7B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$21.5B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.9B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.7B
CAGR 3-Years
3%
CAGR 5-Years
14%
CAGR 10-Years
18%

See Also

What is Intercept Pharmaceuticals Inc's Gross Profit?
Gross Profit
317.1m USD

Based on the financial report for Sep 30, 2023, Intercept Pharmaceuticals Inc's Gross Profit amounts to 317.1m USD.

What is Intercept Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
14%

Over the last year, the Gross Profit growth was 15%. The average annual Gross Profit growth rates for Intercept Pharmaceuticals Inc have been 3% over the past three years , 14% over the past five years .

Back to Top